Accessibility Menu
iSpecimen logo

iSpecimen

(NASDAQ) ISPC

Current Price$2.79
Market Cap$3.95M
Since IPO (2021)-100%
5 YearN/A
1 Year-94%
1 Month-35%

iSpecimen Financials at a Glance

Market Cap

$3.95M

Revenue (TTM)

$1.03M

Net Income (TTM)

-$11.10M

EPS (TTM)

-$66.08

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.79

Volume

69

Open

$2.75

Previous Close

$2.79

Daily Range

$2.73 - $2.90

52-Week Range

$2.54 - $127.20

Estimated Earnings Date

Aug 4, 2026

ISPC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About iSpecimen

Industry

Health Care Technology

Employees

7

CEO

Katharyn Mulcaire Field, MBA

Headquarters

Woburn, MA 02420, US

ISPC Financials

Key Financial Metrics (TTM)

Gross Margin

-30%

Operating Margin

-10%

Net Income Margin

-11%

Return on Equity

-895%

Return on Capital

-10%

Return on Assets

-2%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.95M

Shares Outstanding

1.44M

Volume

69

Avg. Volume

961.31K

Financials (TTM)

Gross Profit

$24.11K

Operating Income

-$8.98M

EBITDA

-$8.75M

Operating Cash Flow

-$4.24M

Capital Expenditure

-$454.00

Free Cash Flow

-$4.24M

Cash & ST Invst.

$6.88M

Total Debt

$268.80K

iSpecimen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$156.01K

-85.2%

Gross Profit

$71.60K

-82.1%

Gross Margin

45.89%

N/A

Market Cap

$3.95M

N/A

Market Cap/Employee

$164.68K

N/A

Employees

24

N/A

Net Income

-$2.28M

-37.2%

EBITDA

-$2.14M

-77.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$2.82M

+260.2%

Total Debt

$254.99K

-15.0%

Accounts Receivable

$132.85K

-77.2%

Inventory

$0.00

N/A

Long Term Debt

$195.96K

-23.2%

Short Term Debt

$59.03K

+30.7%

Return on Assets

-1.68%

N/A

Return on Invested Capital

-9.78%

N/A

Free Cash Flow

-$3.36M

-206.8%

Operating Cash Flow

-$3.36M

-206.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSCSHeartSciences Inc.
$1.80-4.26%
NDRAENDRA Life Sciences Inc.
$4.56+2.70%
GLMDGalmed Pharmaceuticals Ltd.
$0.61-0.63%
SHPHShuttle Pharmaceuticals Holdings, Inc.
$3.91-6.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
SMCISuper Micro Computer
$30.46-0.05%

Questions About ISPC

What is the current price of iSpecimen?

iSpecimen is trading at $2.79 per share.

What is the 52-week range for iSpecimen?

Over the past 52 weeks, iSpecimen has traded between $2.54 and $127.20.

How much debt does iSpecimen have?

As of the most recent reporting period, iSpecimen reported total debt of $254.99K.

How much cash does iSpecimen have on hand?

iSpecimen reported $2.82M in cash and cash equivalents in its most recent financial results.

What is iSpecimen’s dividend yield?

iSpecimen does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.